BP control in Severe Hypertension: Combination of Amlodipine and Telmisartan more efficacious than monotherapy Hina Zahid5 Jun 2021 5:45 AM GMTIndia at the brink of a hypertension epidemic!Globally >1 billion adults suffer from hypertension and this figure is expected to rise to 1.5 billion...
Amlodipine and Atenolol - The two most time-tested anti-hypertensives of 21st century dr. Abhimanyu Uppal27 April 2021 7:12 AM GMTCardiovascular disease is the leading cause of death worldwide, and hypertension is a modifiable risk factor for cardiovascular disease. Risk...
Amlodipine, Telmisartan Combination better than Monotherapy: TEAMSTA 5 Study Dr. Prem Aggarwal13 April 2021 7:15 AM GMTThe hypertensive pressure continues to mount!Hypertension or high blood pressure (BP) affects 1.39 billion people worldwide. Nearly 25% men and 20%&nbs...
NPPA Fixes Retail Price Of 41 Formulations; Details Medical Dialogues Team19 March 2021 8:14 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
Efficacy of Amlodipine as an anti Hypertensive in India: Results from a real-world study Dr. Kamal Kant Kohli8 Dec 2020 6:32 AM GMTNew Delhi: Amlodipine prescribed as monotherapy or add-on therapy during routine clinical practice significantly reduced BP in≤45- and≥65-year-old...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 7:15 AM GMTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Single-pill Triple Drug combination of Perindopril, Indapamide, Amlodipine shows robust efficacy, safety in Indian patients: JAPI Dr. Prem Aggarwal24 Nov 2020 4:30 AM GMTA triple-drug single-pill combination (SPC) containing Perindopril, Indapamide, and Amlodipine has shown excellent safety, efficacy as well as...
Role of Azelnidipine on management of BP in hypertensive Diabetics: Review Dr. Prem Aggarwal4 Nov 2020 5:39 AM GMTHypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to ...
BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Dr. Prem Aggarwal13 Oct 2020 6:47 AM GMTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal ...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Dr. Prem Aggarwal10 Oct 2020 5:00 AM GMTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
Effects of Azelnidipine versus Amlodipine on LV Mass and Longitudinal Function in Hypertensive Patients with LVH Dr. Prem Aggarwal19 Sep 2020 5:30 AM GMTLeft ventricular hypertrophy (LVH) is the structural remodelling of the heart which is a serious consequence of systemic hypertension. It is a...
Amlodipine and its Efficiency in Cardioprotection: Review Dr. Prem Aggarwal7 Sep 2020 7:15 AM GMTCardiovascular diseases (CVD) are the leading causes of death worldwide (1). As per Lancet's Global Burden of Disease Study 1990–2016 in India,...
